COVID-19 puts Amazon growth on steroids, Q2 earnings surge

602
SHARE

The price target increased by 35% to $4,050 from $3,000. 

During this time, Prime member growth accelerated both in the U.S. and internally.

JPMorgan also highlighted “The strength in the grocery category, performance with a delivery capacity increase of 160% and overall grocery sales triple in the second quarter.” This was happened in response to a consumer shift to e-commerce as people were forced to limit their trips to physical stores.

The company was already having impressive long-term growth. But the coronavirus crisis has put that growth on steroids.

————————————————–

Have a story you want USA Herald to cover? Submit a tip here and if we think it’s newsworthy, we’ll follow up on it.

Want guaranteed coverage? We also offer contract journalism here.  Just be sure you’re comfortable giving up editorial control, because our journalists are dogged and will follow the story through to it’s conclusion. The story will be published to our exacting standards, without regard for your preferred slant.